{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:31:50Z","timestamp":1753893110897,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Whether intramuscular depot medroxyprogesterone acetate (DMPA-IM) and norethisterone enanthate (NET-EN) have a differential impact on the incidence of sexually transmitted infection (STI) remains unclear. In the Vaginal and Oral Interventions to Control the Epidemic (VOICE) trial, HIV-1 acquisition was higher for DMPA-IM users vs. NET-EN users. We compared DMPA-IM and NET-EN users with regard to chlamydia, gonorrhea, trichomoniasis, syphilis, and herpes simplex virus type 2 (HSV-2) infection.<\/jats:p><jats:p><jats:bold>Materials and Methods:<\/jats:bold> Prospective data were analyzed from VOICE, a randomized trial of HIV-1 chemoprophylaxis. Participants were evaluated annually and as indicated for chlamydia, gonorrhea, trichomoniasis, and syphilis. Stored specimens were tested for HSV-2. Proportional hazards models compared the risk of STI between DMPA-IM and NET-EN users.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Among 2,911 injectable contraception users in South Africa, 1,800 (61.8%) used DMPA-IM and 1,111 used NET-EN (38.2%). DMPA-IM and NET-EN users did not differ in baseline chlamydia: 15.1 vs. 14.3%, <jats:italic>p<\/jats:italic> = 0.54; gonorrhea: 3.4 vs. 3.7%, <jats:italic>p<\/jats:italic> = 0.70; trichomoniasis: 5.7 vs.5.0%, <jats:italic>p<\/jats:italic> = 0.40; or syphilis: 1.5 vs. 0.7%, <jats:italic>p<\/jats:italic> = 0.08; but differed for baseline HSV-2: (51.3 vs. 38.6%, <jats:italic>p<\/jats:italic> &amp;lt; 0.001). Four hundred forty-eight incident chlamydia, 103 gonorrhea, 150 trichomonas, 17 syphilis, and 48 HSV-2 infections were detected over 2,742, 2,742, 2,783, 2,945, and 756 person-years (py), respectively (chlamydia 16.3\/100 py; gonorrhea 3.8\/100 py; trichomoniasis 5.4\/100 py; syphilis 0.6\/100 py; HSV-2 6.4\/100 py). Comparing DMPA-IM with NET-EN users, no difference was noted in the incidence of chlamydia, gonorrhea, trichomoniasis, syphilis, or HSV-2 infections, including when adjusted for confounders [chlamydia (aHR 1.03, 95% CI 0.85\u20131.25), gonorrhea (aHR 0.88, 95% CI 0.60\u20131.31), trichomoniasis (aHR 1.07, 95% CI 0.74\u20131.54), syphilis (aHR 0.41, 95% CI 0.15\u20131.10), and HSV-2 (aHR 0.83, 95% CI 0.45\u20131.54, <jats:italic>p<\/jats:italic> = 0.56)].<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> Among South African participants enrolled in VOICE, DMPA-IM and NET-EN users differed in prevalence of HSV-2 at baseline but did not differ in the incidence of chlamydia, gonorrhea, trichomoniasis, syphilis, or HSV-2 infection. Differential HIV-1 acquisition, previously demonstrated in this cohort, does not appear to be explained by differential STI acquisition. However, the high incidence of multiple STIs reinforces the need to accelerate access to comprehensive sexual and reproductive health services.<\/jats:p>","DOI":"10.3389\/frph.2021.668685","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T10:25:00Z","timestamp":1626431100000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa"],"prefix":"10.3389","volume":"3","author":[{"given":"Lisa M.","family":"Noguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne M.","family":"Marrazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon L.","family":"Hillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer E.","family":"Balkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thesla","family":"Palanee-Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonasagrie","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindre","family":"Panchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanna","family":"Piper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailazarid","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita","family":"Ramjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. Mike","family":"Chirenje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(12)62204-1","article-title":"National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis","volume":"381","author":"Alkema","year":"2013","journal-title":"Lancet."},{"year":"2011","key":"B2","article-title":"Family Planning: A Global Handbook for Providers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/bmjsrh-2019-200509","article-title":"Hormonal contraception and HIV acquisition among women: an updated systematic review","volume":"46","author":"Curtis","year":"2020","journal-title":"BMJ Sex Reprod Health."},{"key":"B4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1067\/mob.2001.115862","article-title":"Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study","volume":"185","author":"Baeten","year":"2001","journal-title":"Am J Obstet Gynecol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/01.olq.0000137904.56037.70","article-title":"Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections","volume":"31","author":"Morrison","year":"2004","journal-title":"Sex Transm Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.contraception.2009.06.007","article-title":"Use of injectable progestin contraception and risk of STI among South African women","volume":"80","author":"Pettifor","year":"2009","journal-title":"Contraception."},{"key":"B7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jadohealth.2012.04.007","article-title":"Depot medroxyprogesterone acetate use is not associated with risk of incident sexually transmitted infections among adolescent women","volume":"52","author":"Romer","year":"2013","journal-title":"J Adolesc Health."},{"key":"B8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(19)31288-7","article-title":"HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial","volume":"394","year":"2019","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/sextrans-2020-054590","article-title":"Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant","volume":"97","author":"Deese","year":"2020","journal-title":"Sex Transm Infect"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S0140-6736(19)33112-5","article-title":"ECHO: context and limitations","volume":"395","author":"Marrazzo","year":"2020","journal-title":"Lancet."},{"year":"2019","key":"B11","article-title":"Guidance Statement: Recommendations on Contraceptive Methods Used by Women at High Risk of HIV"},{"key":"B12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.contraception.2018.12.001","article-title":"Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women","volume":"99","author":"Heffron","year":"2019","journal-title":"Contraception."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e13287","DOI":"10.1111\/aji.13287","article-title":"Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives","volume":"84","author":"Achilles","year":"2020","journal-title":"Am J Reprod Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S2352-3018(15)00058-2","article-title":"Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study","volume":"2","author":"Noguchi","year":"2015","journal-title":"Lancet HIV."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6963-1-4","article-title":"Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa","volume":"1","author":"Smit","year":"2001","journal-title":"BMC Health Serv Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1742-6405-11-31","article-title":"High prevalence and incidence of sexually transmitted infections among women living in Kwazulu-Natal, South Africa","volume":"11","author":"Naidoo","year":"2014","journal-title":"AIDS Res Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1097\/QAD.0000000000002260","article-title":"Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study","volume":"33","author":"Palanee-Phillips","year":"2019","journal-title":"AIDS."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e25257","DOI":"10.1002\/jia2.25257","article-title":"Acquisition of sexually transmitted infections among women using a variety of contraceptive options: a prospective study among high-risk African women","volume":"22","author":"Kiweewa","year":"2019","journal-title":"J Int AIDS Soc."},{"key":"B19","unstructured":"Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine\/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women2008"},{"key":"B20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"Marrazzo","year":"2015","journal-title":"N Engl J Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/10158782.2009.11441341","article-title":"Revision of the national guideline for first-line comprehensive management and control of sexually transmitted infections: what's new and why?","volume":"24","author":"Lewis","year":"2009","journal-title":"South Afr J Epidemiol Infect."},{"key":"B22","unstructured":"Selected Practice Recommendations for Contraceptive Use: 2008 Update2008"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox's regression model for counting processes: a large sample study","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Statist."},{"key":"B24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.contraception.2016.07.128","article-title":"Misreporting of contraceptive hormone use in clinical research participants","volume":"97","author":"Achilles","year":"2018","journal-title":"Contraception"},{"key":"B25","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/QAD.0000000000000036","article-title":"Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches","volume":"27","author":"Polis","year":"2013","journal-title":"AIDS."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex Transm Infect."},{"key":"B27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1600-0897.2010.00930.x","article-title":"Hormonal contraception and HIV-1 transmission","volume":"65","author":"Blish","year":"2011","journal-title":"Am J Reprod Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1177\/0956462420915388","article-title":"Estimating prevalence and incidence of sexually transmitted infections among South African women: implications of combined impacts of risk factors","volume":"31","author":"Wand","year":"2020","journal-title":"Int J STD AIDS."},{"article-title":"Provider Brief: Does Hormonal Contraception Modify the Risk of STI Acquisition?","year":"2007","author":"Kapp","key":"B29"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2021.668685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T10:25:06Z","timestamp":1626431106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2021.668685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":29,"alternative-id":["10.3389\/frph.2021.668685"],"URL":"https:\/\/doi.org\/10.3389\/frph.2021.668685","relation":{},"ISSN":["2673-3153"],"issn-type":[{"type":"electronic","value":"2673-3153"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"article-number":"668685"}}